Pediatric systems medicine: evaluating needs and opportunities using congenital heart block as a case study

Jesper Tegnér1, Imad Abugessaisa

  • 1Department of Medicine, Unit of Computational Medicine, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Solna, Stockholm, Sweden. jesper.tegner@ki.se

Pediatric Research
|February 2, 2013
PubMed

Insights

Developing user-friendly bioinformatics tools is crucial for integrating omics and clinical data to advance preventive pediatric medicine. This approach aids in predicting and preventing diseases like congenital heart block.

Area of Science:

  • Biomedical Informatics
  • Systems Medicine
  • Pediatric Research

Background:

  • Healthcare is shifting towards preventive strategies, driven by advances in molecular profiling and disease analysis.
  • Significant informatics challenges hinder the integration of diverse data types for a systems medicine approach.

Purpose of the Study:

  • To identify key informatics challenges in developing a systems medicine approach for disease prevention and prediction.
  • To use congenital heart block (CHB) as a model to illustrate these challenges.

Main Methods:

  • Analysis of existing bioinformatics tools for integrative data analysis.
  • Evaluation of data management solutions in a clinical context.

Main Results:

  • A scarcity of bioinformatics tools for integrating molecular and clinical data in specific disease contexts like CHB.
  • Existing data management systems require substantial software engineering support beyond clinician capabilities.

Conclusions:

  • There is a critical need for accessible tools that integrate omics data and clinical information for systems medicine.
  • Pediatrics offers a unique opportunity for collaborative systems medicine initiatives focused on disease prevention and wellness.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...